Education
About Us
Working with TipRanks
Follow Us
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
Mnpr-101-Pcta-177Lu
Ovarian Cancer, Bladder Cancer, Urothelial Carcinoma, Colorectal Cancer, Pancreatic Cancer, Lung Cancer, Gastric Cancer, Triple-Negative Breast Cancer, Solid Tumor, Adult
Phase I
Recruiting
Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors
Sep 18, 2024
―
Mnpr-101-Dfo*-89Zr, Pet/Ct Diagnostic Imaging
Ovarian Cancer, Bladder Cancer, Urothelial Carcinoma, Colorectal Cancer, Pancreatic Cancer, Lung Cancer, Gastric Cancer, Triple-Negative Breast Cancer, Solid Tumor, Adult
Phase I
Recruiting
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
Mar 22, 2024
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Monopar Therapeutics Inc (MNPR) have in its pipeline
MNPR is currently developing the following drugs: Mnpr-101-Pcta-177Lu, Mnpr-101-Dfo*-89Zr, Pet/Ct Diagnostic Imaging. These drug candidates are in various stages of clinical development as the company works toward FDA approval.